Dr. Greg Riely, medical oncologist from MSKCC, considers the evidence on whether there are clinically significant differences among the currently available first and second generation oral EGFR inhibitors for patients...
show moreAuthor | cancerGRACE |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Browse Spreaker Catalogue to discover great new content
Browse Spreaker Catalogue to discover great new content
It's so quiet here...
Time to discover new episodes!